Rabies Immune Globulin (Human) from Canada
This human-derived antiserum provides passive immunity against rabies virus post-exposure, consisting of purified IgG antibodies from vaccinated donors. Classified in HTS 3002.12.00 as antisera and blood fractions for prophylactic use. It is administered intramuscularly alongside vaccine for high-risk exposures.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide WHO prequalification or equivalent for expedited clearance in emergency imports
• Declare exact potency (IU/mL) on commercial invoice to match therapeutic labeling
• Comply with IATA dangerous goods rules for biological substances Category B shipping